JAMES SMITH: Open Payments
NPI 1053395129 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 52 payments from 19 companies in 2025. Trend: 2023 $940 · 2024 $1,236 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $136 |
| SANOFI-AVENTIS U.S. LLC | 6 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| ABBVIE INC. | 4 | $65 |
| Inspire Medical Systems, Inc. | 2 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| PFIZER INC. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: TZIELD, JARDIANCE, SHINGRIX, INSPIRE, XIFAXAN, Ozempic, Wegovy, SPRAVATO.
Industry payments across GA — which companies pay providers there.
